|1.||Bai, Linquan: 1 article (07/2015)|
|2.||Kang, Qianjin: 1 article (07/2015)|
|3.||Liu, Jing: 1 article (07/2015)|
|4.||Jiang, Chunyan: 1 article (07/2015)|
|5.||Jiang, Ming: 1 article (07/2015)|
|6.||Qi, Zhen: 1 article (07/2015)|
|7.||Shi, Pei-Yong: 1 article (06/2010)|
|8.||Lim, Siew Pheng: 1 article (06/2010)|
|9.||Dong, Hongping: 1 article (06/2010)|
|10.||Chao, Alexander Theodore: 1 article (06/2010)|
01/01/1994 - "Relapses were observed after discontinuation of curative sinefungin therapy, which suggests that the biliary tract, a major location and parasite reservoir which sustains persisting infection, was not cleared of parasites by the drug. "
01/01/2009 - "Shedding relapses observed after discontinuation of sinefungin therapy lead to identify the bile ducts as a protected reservoir that may sustain chronic infection. "
01/01/1994 - "Oral sinefungin therapy resulted in a dose related suppression of oocysts shedding, which correlated with oocyst disappearance from ileum sections and was also efficient in preventing infection. "
04/01/1993 - "When administered prior to or on the day of oocyst challenge, sinefungin successfully prevented infection. "
01/01/1989 - "Antileishmanial effect of free and encapsulated sinefungin against Leishmania donovani infections in BALB/c mice."
|2.||Dengue (Dengue Fever)
01/01/2009 - "Anticryptosporidial pharmacological and/or immunological agents were initially tested in immunodeficient models of cryptosporidiosis, and sinefungin exhibited a significant dose dependent curative and preventive activity. "
04/01/1993 - "These data suggest that sinefungin could be considered as a candidate molecule in the treatment of human cryptosporidiosis, considered to be the most significant enteric opportunistic infection in AIDS."
|5.||Subacute Combined Degeneration
01/01/1986 - "Cells treated with 30 microM sinefungin, which inhibits myelin basic protein methyltransferase in broken cell preparations about 60%, produced ringlike structures that were devoid of multilamellar periodicity and compactness reminiscent of the vacuolated myelin observed in subacute combined degeneration and in nitrous-oxide- or cycloleucine-treated animals in which methyltransferase activity is also inhibited. "
|5.||Messenger RNA (mRNA)
|6.||RNA (Ribonucleic Acid)
|7.||Nitrous Oxide (Laughing Gas)